BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26344755)

  • 1. The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models.
    Rubino T; Parolaro D
    Biol Psychiatry; 2016 Apr; 79(7):578-85. PubMed ID: 26344755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
    Schneider M
    Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis abuse in adolescence and the risk of psychosis: a brief review of the preclinical evidence.
    Rubino T; Parolaro D
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():41-4. PubMed ID: 23916409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and adolescent brain development.
    Lubman DI; Cheetham A; Yücel M
    Pharmacol Ther; 2015 Apr; 148():1-16. PubMed ID: 25460036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
    Rubino T; Zamberletti E; Parolaro D
    J Psychopharmacol; 2012 Jan; 26(1):177-88. PubMed ID: 21768160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
    López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
    Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Laboratory Studies on Cannabinoids and Psychosis.
    Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
    Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.
    Malone DT; Hill MN; Rubino T
    Br J Pharmacol; 2010 Jun; 160(3):511-22. PubMed ID: 20590561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.
    Zamberletti E; Beggiato S; Steardo L; Prini P; Antonelli T; Ferraro L; Rubino T; Parolaro D
    Neurobiol Dis; 2014 Mar; 63():35-47. PubMed ID: 24200867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Psychiatric Consequences of Cannabinoids.
    De Aquino JP; Sherif M; Radhakrishnan R; Cahill JD; Ranganathan M; D'Souza DC
    Clin Ther; 2018 Sep; 40(9):1448-1456. PubMed ID: 29678279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
    Bossong MG; Niesink RJ
    Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
    Di Forti M; Morrison PD; Butt A; Murray RM
    Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system: emotion, learning and addiction.
    Moreira FA; Lutz B
    Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
    Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E
    Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis-associated psychosis: Neural substrate and clinical impact.
    Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
    Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.
    Campolongo P; Trezza V; Palmery M; Trabace L; Cuomo V
    Int Rev Neurobiol; 2009; 85():117-33. PubMed ID: 19607965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.
    Realini N; Rubino T; Parolaro D
    Pharmacol Res; 2009 Aug; 60(2):132-8. PubMed ID: 19559364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
    Cohen M; Solowij N; Carr V
    Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.